Huanhuan Chen

No. 36, San Hao Street
Shenyang, 110004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Circulating metabolites in plasma reveal potential target of lung cancer prevention: insights from fatty acids pathway.

Circulating metabolites in plasma reveal potential target of lung cancer prevention: insights from fatty acids pathway.

Journal: Nutrition journal

Published: May 20, 2025

Systematic review and meta-analysis of artificial intelligence for image-based lung cancer classification and prognostic evaluation.

Systematic review and meta-analysis of artificial intelligence for image-based lung cancer classification and prognostic evaluation.

Journal: NPJ precision oncology

Published: November 14, 2024

Associations between carbohydrate quality and the survival of, and life expectancy with lung cancer patient: A prospective cohort study.

Associations between carbohydrate quality and the survival of, and life expectancy with lung cancer patient: A prospective cohort study.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: August 23, 2024

Radiomics based on brain-to-tumor interface enables prediction of metastatic tumor type of brain metastasis: a proof-of-concept study.

Radiomics based on brain-to-tumor interface enables prediction of metastatic tumor type of brain metastasis: a proof-of-concept study.

Journal: La Radiologia medica

Published: July 04, 2024

Improved Prediction of Epidermal Growth Factor Receptor Status by Combined Radiomics of Primary Nonsmall-Cell Lung Cancer and Distant Metastasis.

Improved Prediction of Epidermal Growth Factor Receptor Status by Combined Radiomics of Primary Nonsmall-Cell Lung Cancer and Distant Metastasis.

Journal: Journal of computer assisted tomography

Published: March 18, 2024

LSM12 promotes the lung squamous cell carcinoma progression through mediating alternative splicing of ARRB1.

LSM12 promotes the lung squamous cell carcinoma progression through mediating alternative splicing of ARRB1.

Journal: Communications biology

Published: March 06, 2024

Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.

Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.

Journal: Journal of computer assisted tomography

Published: November 10, 2023

KCTD15 acts as an anti-tumor factor in colorectal cancer cells downstream of the demethylase FTO and the m6A reader YTHDF2.

KCTD15 acts as an anti-tumor factor in colorectal cancer cells downstream of the demethylase FTO and the m6A reader YTHDF2.

Journal: Communications biology

Published: June 21, 2023

Radiomics signatures for predicting the Ki-67 level and HER-2 status based on bone metastasis from primary breast cancer.

Radiomics signatures for predicting the Ki-67 level and HER-2 status based on bone metastasis from primary breast cancer.

Journal: Frontiers in cell and developmental biology

Published: May 12, 2023

Brain-Tumor Interface-Based MRI Radiomics Models to Determine EGFR Mutation, Response to EGFR-TKI and T790M Resistance Mutation in Non-Small Cell Lung Carcinoma Brain Metastasis.

Brain-Tumor Interface-Based MRI Radiomics Models to Determine EGFR Mutation, Response to EGFR-TKI and T790M Resistance Mutation in Non-Small Cell Lung Carcinoma Brain Metastasis.

Journal: Journal of magnetic resonance imaging : JMRI

Published: February 21, 2023

Comprehensive analysis of prediction of the EGFR mutation and subtypes based on the spinal metastasis from primary lung adenocarcinoma.

Comprehensive analysis of prediction of the EGFR mutation and subtypes based on the spinal metastasis from primary lung adenocarcinoma.

Journal: Frontiers in oncology

Published: January 30, 2023

A deep learning-based system for survival benefit prediction of tyrosine kinase inhibitors and immune checkpoint inhibitors in stage IV non-small cell lung cancer patients: A multicenter, prognostic study.

A deep learning-based system for survival benefit prediction of tyrosine kinase inhibitors and immune checkpoint inhibitors in stage IV non-small cell lung cancer patients: A multicenter, prognostic study.

Journal: EClinicalMedicine

Published: April 04, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026